Gene · 6281
NIH grants2,552
NIH grants whose papers are about the gene, through NIH's grant-paper links.
941 to 960 of 2,552
Download this page as JSON| Grant | Title | S100A10 papers | Newest fiscal year |
|---|---|---|---|
| R01AI118799 | Functional Analyses of Borrelia burgdorferi Adhesins | 1 | 2020 |
| R01AI121012 | Epac1 Plays a Critical Role in Bacterial Adhesion during Rickettsioses | 1 | 2020 |
| R01AI121196 | Role of Protein Ubiquitination in Sepsis | 1 | 2020 |
| R01AI121832 | A protective role for gamma delta T cells in respiratory infection | 1 | 2020 |
| R01AI123070 | HIGH-THROUGHPUT EPITOPE DISCOVERY: USE OF NEXT-GENERATION PEPTIDE CHIPS FOR FAST IDENTIFICATION AND FINE MAPPING OF DIAGNOSTIC AND PROGNOSTIC MARKERS FOR CHAGAS DISEASE | 1 | 2020 |
| R01AI123253 | Regulation of Innate Immune System Sensing of C. Albicans Infections | 1 | 2020 |
| R01AI123284 | Non-Canonical Cross-presentation in Dendritic Cells Upon TAP Blockade | 1 | 2020 |
| R01AI123406 | Non-canonical mechanisms of translation of viral mRNAs | 1 | 2020 |
| R01AI124121 | Restoring macrophage function in cystic fibrosis | 1 | 2020 |
| R01AI150454 | Structure and Assembly of Retroviruses | 1 | 2020 |
| R01AR067705 | Regulation of B cell activation in lupus | 1 | 2020 |
| R01CA049152 | Signal Transduction by Non-Transmembrane PTPs | 1 | 2020 |
| R01CA055349 | Improving specificity of therapeutic antibodies for cancer. | 1 | 2020 |
| R01CA105412 | Transmembrane Proteins Involved in Human Tumor Expansion | 1 | 2020 |
| R01CA161373 | Molecular pathogenesis of intestinal serrated polyps | 1 | 2020 |
| R01CA163507 | Innate signaling pathways in colitis and colorectal tumorigenesis | 1 | 2020 |
| R01CA174949 | Developing targeted therapies for triple-negative breast cancer | 1 | 2020 |
| R01CA196882 | Characterizing Histone Deacetylases in Rhabdomyosarcoma | 1 | 2020 |
| R01CA198291 | Preclinical Testing of a Novel Therapy Targeting AXL in Advanced Kidney Cancer | 1 | 2020 |
| R01CA200859 | Hardwiring Mechanism into Predicting Cancer Phenotypes by Computational Learning | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6281/grants?page=48